← Back to Search

Dietary Supplement

Arm I (omega-3 fatty acid) for Joint Pain

N/A
Waitlist Available
Led By Maryam Lustberg, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This study is evaluating whether omega-3 fatty acids may help reduce bone pain and joint pain in patients with breast cancer.

Eligible Conditions
  • Joint Pain
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pain score based on the Brief Pain Inventory (BPI)
Secondary outcome measures
Change in joint symptoms based on quality of life instruments
Change in joint symptoms based on symptomatology instruments
Identification and validation of genetic risk predictors for aromatase inhibitor-induced arthralgias
+2 more
Other outcome measures
Level of inflammatory markers
Red blood cells (RBC) n-3 PUFA levels

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Arm I (omega-3 fatty acid)Active Control1 Intervention
Patients receive omega-3 fatty acid supplementation PO QD for 6 months.
Group II: Arm II (placebo)Placebo Group1 Intervention
Patients receive placebo PO QD for 6 months.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,078 Total Patients Enrolled
1 Trials studying Joint Pain
42 Patients Enrolled for Joint Pain
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,092 Total Patients Enrolled
Maryam Lustberg, MD5.08 ReviewsPrincipal Investigator - Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
4 Previous Clinical Trials
280 Total Patients Enrolled
5Patient Review
She is an excellent doctor who is very caring and takes as much time with you as needed. She has called me after hours to review test results with me. I am also able to send emails directly to her and she has responded after hours and on weekends to these. I couldn’t ask for a better doctor.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Nicole Williams 2016. "Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02831582.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top